← Leaderboards
Benjamin P Warner
Icagen, Inc.
$4,878,296
Attributed
$4,878,296
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,878,296 · 7
By mechanism
R44$3,000,000 · 1
R43$1,878,296 · 6
Top collaborators
No co-investigators on record.
Most similar at Icagen, Inc.
Same institution · by research overlap
- Eva R Birnbaum$594,695
- Doug Krafte$300,000
Others in their field
Top investigators on “Binding (Molecular Function)”
- David Heimbrook · Leidos Biomedical Research, Inc.$99,890,135
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Dennis R. Burton · Scripps Research Institute$64,421,085
- Michael P Snyder · Yale University$62,252,853
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$48,139,978
- Barton F Haynes · Duke University$39,418,096
Research focus
Binding (Molecular Function)United States National Institutes Of HealthLeadTechnologyFluorescenceLibrariesMetalsMeasurementProtocols DocumentationHigh Throughput ScreeningPharmacologic SubstanceProtein BindingPharmaceutical PreparationsRadioactiveIn VivoSamplingKineticsDoseCellsLabelCalciumEmergency SituationOralInstrument
Grant awards (11)
Removal of Palladium from Pharmaceutical Process Chemistry Reactions$280,160
R43 · FY2025 · GM · contact PI
XRpro Radioactive Cesium Decorporation Agents$300,000
R43 · FY2014 · AI · contact PI
Selective Decorporation Agents for NIAID$1,000,000
R44 · FY2013 · AI · contact PI
Selective Decorporation Agents for NIAID$1,000,000
R44 · FY2012 · AI · contact PI
Selective Decorporation Agents for NIAID$1,000,000
R44 · FY2011 · AI · contact PI
XRpro Discovery of Decorporation Agents$300,000
R43 · FY2010 · AI · contact PI
XRpro Technology for the Detection and Evaluation of Carcinogens$200,000
R43 · FY2010 · CA · contact PI
Probes for Transient Kinase Complexes$98,917
R43 · FY2010 · GM · contact PI
XRpro Discovery of Decorporation Agents$300,000
R43 · FY2009 · AI · contact PI
Novel Micro-X-ray Translucent Flow Cell Technology for Proteomics, a Broadly Appl$178,915
R43 · FY2009 · GM · contact PI
Novel Micro-X-ray Translucent Flow Cell Technology for Proteomics, a Broadly Appl$220,304
R43 · FY2008 · GM · contact PI